Catch up on recent developments at Frontier IP in our latest quarterly newsletter
Learn more about The Vaccine Group’s approach to COVID-19 and why AI-driven drug discovery is at a tipping point. Plus developments from Nandi Proteins, Fieldwork Robotics, Cambridge Raman Imaging and more.
Read moreFrontier supports technology to eradicate detectable TCA from natural cork stoppers
The world’s leading producer of cork products, Corticeira Amorim, has announced a breakthrough technology to remove the major cause of cork taint in wine from natural corks. Learn more about Frontier IP’s role in the development.
Read moreLearn how Elute Intelligence can make your FTO searches faster and easier
Register at https://eluteintelligence.com/registration/ to join Coller IP’s Head of IP Strategy Richard Nugent on 24 February at 15.30 GMT / 16.30 CET to learn how Elute’s novel technology can make your FTO searches more efficient.
Read moreFrontier IP appoints Director of Corporate Relationships to support portfolio fundraisings
Frontier IP is delighted to announcement appointment of Darren Winter, a former senior sales director with more than 30 years’ City experience, as Director of Corporate Relationships, a non-board role.
Read moreElute Intelligence raises £250,000 in first equity fund raising
Portfolio company Elute Intelligence Holdings raises £250,000 in return for 10 per cent of the company to accelerate development of Patent Reader and enterprise search tool.
Read moreCambridge Raman Imaging is part of EUR5m project to develop groundbreaking medical imaging technology
Portfolio company to commercialise technology based on advanced laser techniques and artificial intelligence to show how diseases unfold at a molecular level in near real time.
Read moreFieldwork Robotics to develop robot simulator after winning grant from Innovate UK’s Sustainable Innovation Fund
Fieldwork Robotics is to develop a digital simulator of its robotics technology with support from Bosch, following a £145,000 grant award to help mitigate the effects of COVID-19.
Read moreInvestor presentation for Full Year Results to 30 June 2020 and VSA Capital buy note available now
Our investor presentation for the full year to 30 June is now ready to download alongside an analyst note from VSA Capital, which has initiated coverage with a buy.
Read moreAlusid raises £250,000 including £125,000 from UK government’s Future Fund
Alusid is Frontier’s third portfolio company after Pulsiv Solar and Nandi Proteins to be backed by the Future Fund established to support innovative businesses affected by COVID-19
Read moreFind out what’s been happening at Frontier IP and the portfolio in our new quarterly newsletter
The Vaccine Group, Pulsiv Solar, Elute Intelligence, Alusid and Fieldwork Robotics are among the portfolio companies to feature in our new newsletter.
Read more